OMEPRAZOLE CRISTERS LAB 20 mg, gastro-resistant capsule 14 capsules
Active ingredients: Omeprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule14 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OMEPRAZOLE CRISTERS LAB 20 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s)
- Marketing authorisation holder
- SUN PHARMA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61490953CIP72695408CIP133400926954086Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OMÉPRAZOLEgélule | 20 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.